Drugs / EnBrace HR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04123483 | Nov 2019 → Nov 2021 | premenstrual dysphoric disorder | Massachusetts General Hospital | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EnBrace HR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04123483 ↗ |